The Trump administration’s drug deals, explained
In the closing months of 2025, President Donald Trump’s effort to reshape how Americans pay for prescription drugs has taken clearer form. What started as a campaign threat to slap tariffs on pharmaceutical imports has evolved into a series of deals with some of the world’s largest drugmakers — and a promise that patients in […]
STAT+: Medicaid’s ‘GENEROUS’ pricing may not save states money
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning, morning. Today, we have a trio of interesting studies on cholesterol reduction from the American Heart Association’s meeting in New Orleans. Also, Pfizer wins the Metsera deal with $10 billion, and we look […]
Does Trump’s MFN Policy Put Pharma ETFs in the Crosshairs?
Pharma giants Eli Lily (LLY) and Novo Nordisk (NVO) have signed deals with U.S. President Donald Trump to slash the prices of some of their obesity drugs, including upcoming pills, as per a White House announcement made late last week. This comes as part of the Trump administration’s Most-Favored-Nation (“MFN”) drug pricing policy that aims […]
GPs Urge Specialist Clinics for Weight-Loss Drug Use
At the RCGP Annual Conference, GPs backed specialist-led clinics for prescribing GLP-1 weight-loss drugs, warning against online misuse and over-medicalising obesity. Medscape News UK
Is the White House’s deal with pharma on GLP-1 drugs a game changer? – statnews.com
Is the White House’s deal with pharma on GLP-1 drugs a game changer? statnews.com
Camurus jumps on positive topline result for its once-monthly GLP-1 candidate – TradingView
Camurus jumps on positive topline result for its once-monthly GLP-1 candidate TradingView
STAT+: Is the White House’s deal with pharma on GLP-1 drugs a game changer?
President Trump last week hailed his deal with pharma companies to cut the price of blockbuster weight loss drugs as a major win for his administration and for increasing drug affordability. The question is how big of a difference the agreement will make for patients. The deal is expected to significantly expand access to GLP-1 […]
The Impact of GLP-1 Receptor Agonists on Clinical Outcomes and Healthcare Utilization in Hidradenitis Suppurativa Patients: A Retrospective Cohort Study Using TriNetX
Post Content
First it was Ozempic. Now the peptide gold rush is here — and it’s dangerous
Ozempic changed everything: Millions of Americans who have discovered the transformative power of one peptide are chasing their next fix
Gordon Ramsay calls Ozempic restaurant menus ‘absolute bulls—‘ in profanity-filled rant
Gordon Ramsay didn’t hold back when speaking out on whether he would alter his restaurants’ menus to cater to diners who are taking popular weight loss drugs including Ozempic and Mounjaro. During a recent interview with The Sunday Times, the 59-year-old celebrity chef was asked whether he would create special, smaller-portion menus for patrons using […]